AI driven care The institute is actively developing and deploying AI models for cancer treatment evaluation and brain metastases detection, indicating demand for AI/ML platforms, data pipelines, and AI governance solutions to support research and clinical workflows.

Clinical research scale Close integration of a top research institute with a hospital under one roof suggests opportunities for integrated data analytics, imaging informatics, and translational solutions that bridge research findings to patient care and operational efficiency.

Strategic partnerships Ongoing collaborations with industry and academic partners (MRM Health, Oncode Institute, Borstkanker, MSK, SITC) signal openness to co-development, contract research, and technology licensing, presenting avenues for joint ventures and sponsored research programs.

Immunotherapy focus Presence of key immunology and tumor immunology themes along with notable keynote and conference engagement indicates potential for partnerships in immune-oncology tooling, biomarkers, and trial support platforms.

Global visibility Award recognition (Spinoza Prize) and high-profile publications plus international collaborations position the organization as a credible partner for advanced imaging, AI solutions, and translational research services targeting cancer care improvements.